首页> 外文期刊>Journal of Drug Delivery and Therapeutics >FORMULATION AND DEVELOPMENT OF FENOFIBRATE LOADED LIPOSPHERE SYSTEM
【24h】

FORMULATION AND DEVELOPMENT OF FENOFIBRATE LOADED LIPOSPHERE SYSTEM

机译:纤维状受荷岩石体系的形成与发展

获取原文
           

摘要

Lipospheres offers a new approach to improve the solubility of poorly soluble drug. Fenofibrate is a third-generation fibric acid derivative belonging to BCS class-II, employed clinically as a hypolipidemic agent to lessen the risk caused by atherosclerosis. An attempt was made to improve aqueous solubility of FNO by aid of stearic acid and Paraffin oil. The liposphere of FNO was prepared by melt dispersion technique using ultra turrax with %yield of 38% to 46% followed by their evaluation for saturation solubility, IR spectra, DSC, in-vitro study. Saturation solubility of FNO (92μg/ml) had improved to 184.31μg/ml with physical mixture of stearic and paraffin oil. Therefore, lipospheres of FNO were prepared using melt dispersion technique. The factorial batches were formulated using 3 2 factorial design with variables X1- concentration of stearic acid and X2- concentration of paraffin oil and responses Y1 - % Drug Entrapment (%DE) and Y2 - % Drug Release (% DR). The optimized batch was formulated and evaluated for Saturation Solublity, % DR, Invivo Study Thus from the present study it can be concluded that solubility of BCS class-II drugs can be improved by liposphere system. aid } ?tapf?p?and Paraffin oil. The liposphere of FNO was prepared by melt dispersion technique using ultra turrax with %yield of 38% to 46% followed by their evaluation for saturation solubility, IR spectra, DSC, in-vitro study. Saturation solubility of FNO (92μg/ml) had improved to 184.31μg/ml with physical mixture of stearic and paraffin oil. Therefore, lipospheres of FNO were prepared using melt dispersion technique. The factorial batches were formulated using 3 2 factorial design with variables X1- concentration of stearic acid and X2- concentration of paraffin oil and responses Y1 - % Drug Entrapment (%DE) and Y2 - % Drug Release (% DR). The optimized batch was formulated and evaluated for Saturation Solublity, % DR, Invivo Study Thus from the present study it can be concluded that solubility of BCS class-II drugs can be improved by liposphere system. Keyword: Fenofibrate, Melt dispersion Technique, Liposphere.
机译:脂质体提供了一种新方法来改善难溶性药物的溶解度。非诺贝特是属于BCS II类的第三代纤维酸衍生物,临床上被用作降血脂药以降低由动脉粥样硬化引起的风险。尝试通过硬脂酸和石蜡油改善FNO的水溶性。通过使用Ultra turrax的熔融分散技术制备FNO脂质体,其收率在38%至46%之间,然后评估其饱和溶解度,红外光谱,DSC和体外研究。硬脂和石蜡油的物理混合物将FNO的饱和溶解度(92μg/ ml)提高到184.31μg/ ml。因此,使用熔融分散技术制备了FNO的脂质球。使用3 2阶乘设计配制阶乘批次,变量X1-硬脂酸浓度和X2-石蜡油浓度以及响应Y1-%药物截留(%DE)和Y2-%药物释放(%DR)。配制优化的批次并评估其饱和溶解度,%DR,体内研究。因此,从本研究可以得出结论,脂球系统可以改善BCS II类药物的溶解度。 } tapf?p?和石蜡油。通过使用Ultra turrax的熔融分散技术制备FNO脂质体,其收率在38%至46%之间,然后评估其饱和溶解度,红外光谱,DSC和体外研究。硬脂和石蜡油的物理混合物将FNO的饱和溶解度(92μg/ ml)提高到184.31μg/ ml。因此,使用熔融分散技术制备了FNO的脂质球。使用3 2阶乘设计配制阶乘批次,变量X1-硬脂酸浓度和X2-石蜡油浓度以及响应Y1-%药物截留(%DE)和Y2-%药物释放(%DR)。配制优化的批次并评估其饱和溶解度,%DR,体内研究。因此,从本研究可以得出结论,脂球系统可以改善BCS II类药物的溶解度。关键字:非诺贝特,熔体分散技术,脂质体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号